Atezolizumab Plus Bevacizumab for Unresectable or Metastatic Mucosal Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: a Multicenter, Open-label, Single-arm Phase 2 Study
Clin. Cancer Res 2022 Aug 31;[EPub Ahead of Print], L Mao, M Fang, Y Chen, X Wei, J Cao, J Lin, P Zhang, L Chen, X Cao, Y Chen, J Guo, L SiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.